XBIO Xenetic Biosciences: Company Short-Term Debts
Xenetic Biosciences (XBIO) develops anti-tumor delivery systems, generating revenue through long-term licenses and royalties. Patents create a defensive moat for the business, although success depends on FDA approval. The price action of securities with the 0.00 metric is shown below. The asset is not subject to inflation, as quotes are determined exclusively by medical test results and stable demand for therapy.
XBIO (Xenetic Biosciences Inc.): analytical breakdowns and indicator data
- stock price and consensus target price:
- company stock capitalization data:
- business book valuation details:
- debt and liquidity details:
Total Debt to Capital Xenetic Biosciences|XBIO - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Xenetic Bio|XBIO - Company Aggregate Debts|Debt to Book Capitalization Ratio Xenetic Biosciences, Inc.|XBIO - Company Long-Term Loans and Borrowings|Company Short-Term Debts Xenetic Biosciences|Quick Liquidity Indicator xeneticbio.com
- earnings and multiples data:
Analysis of all company metrics:XBIO - xeneticbio.com
This indicator measures obligations with a maturity of up to one year, determining short-term solvency and the risk of liquidity loss. The trend in current liabilities reflects the financial stability of Xenetic Biosciences (XBIO), as a high dependence on external CROs and outsourced clinical trials requires a constant availability of free cash to fund contracts.
Competing companies
BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|tuhurabio.com - Company Short-Term Indebtedness|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK - Company Short-Term Debt|TCRX (TScan Therapeutics) - Company Short-Term Indebtedness|CSBR: Company Short-Term Debts|Short-Term Debt XBiotech (XBIT)|Company Current Liabilities CVM|OSTX (OS Therapies Inc.) - Amount of Current Liabilities|Company Short-Term Debts RADX|Short-Term Debt Volume artivabio.com|Company Short-Term Debts ANL (Adlai Nortye)|VERU - Company Current Liabilities|TPST: Company Current Liabilities|Company Short-Term Loans and Borrowings XLO (Xilio Therapeutics, Inc.)|RENB: Company Short-Term Debts|MURA (Mural Oncology) - Company Short-Term Debt|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|OnKure (OKUR) - Short-Term Debt Volume|Company Short-Term Debt CytoMed Therapeutics (GDTC)|CRIS - Short-Term Debt|Company Short-Term Debt Apollomics APLM|Short-Term Debt Volume Tharimmune Corporation (THAR)|Advanced Biomed Corp - Company Short-Term Debts|genprex.com (GNPX) - Company Current Liabilities|CLDI: Company Short-Term Debts|SBFM - Short-Term Debt Volume|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Short-Term Debt American Oncology Network (AONC)|beigene.com - Company Short-Term Indebtedness|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|ELEV - Company Current Liabilities|iCAD Corp - Company Short-Term Debts|Short-Term Debt Ikena Oncology, Inc.|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX - Short-Term Debt Volume|Company Current Liabilities MOR|Company Short-Term Indebtedness NAYA (NAYA Biosciences Inc)|Company Short-Term Debts AAPGV